Concepedia

Pharmacogenetic and Germline Prognostic Markers of Lung Cancer

Anne M. Horgan, Boming Yang, Abul Kalam Azad, Eitan Amir, Thomas John, David W. Cescon, Paul Wheatley‐Price, Rayjean J. Hung, Frances A. Shepherd, Geoffrey Liu

Journal of Thoracic Oncology · 2011 · 38 citations · 75 references

DOIFull text

Open access

Concepts

References

75

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella et al. · New England Journal of Medicine · 2004 · 11.4K citations

The Structure of Haplotype Blocks in the Human Genome

Stacey Gabriel, S. F. Schaffner, Huy Nguyen et al. · Science · 2002 · 5.8K citations

, , +18

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer

Mark G. Kris, Ronald B. Natale, Roy S. Herbst et al. · JAMA · 2003 · 2.5K citations

Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome

Ming‐Sound Tsao, Akira Sakurada, Jean-Claude Cutz et al. · New England Journal of Medicine · 2005 · 1.8K citations

High-resolution haplotype structure in the human genome

Mark J. Daly, John D. Rioux, S. F. Schaffner et al. · Nature Genetics · 2001 · 1.7K citations

, , +4